Cancer multiplicities in the Czech population
Authors:
Edvard Geryk 1; Petr Dítě 1; Jiří Kozel 2; Petr Kubíček 2; Milan Konečný 2; Radim Štampach 2; Miloš Pešek 3
Authors place of work:
Fakultní nemocnice Brno – Bohunice
1; Masarykova univerzita Brno, Přírodovědecká fakulta, Geografický ústav
2; Fakultní nemocnice Plzeň
3
Published in the journal:
Čas. Lék. čes. 2010; 149: 178-183
Category:
Original Article
Summary
During 1976–2005 the Czech Cancer Registry registered 1.486,984 neoplasms of categories ICD-10: C00-D48, of which were notified 290,312 (19.5%) multiple cases. There were 65,292 primary diseases in men and 59,970 in women, 89,796 subsequent neoplasms in men and 75,254 in women. The duplicities were higher in men and multiplicities higher in women. The multiple cases there were 19.5% of total new diagnosed neoplasms in men and 18.5% in women, without the skin cancers there were 13.7% in men and 13.6% in women. The most frequent were primary cancers of skin 46%, digestive tract 13.5%, urinary tract 9.6%, genital organs 8.1%, respiratory and intrathoracic organs 7.8% in men and cancers of skin 39.4%, breast 17.3%, genital organs 14.6%, and digestive tract 9.8% in women. The highest percentage of multiplicities in new diagnosed cases were cancers of skin 56.4%, melanoma 22.7%, urinary tract 19.9%, oral cavity 17.8%, genital organs 16.4%, endocrine glands 15.8% and haemopoietic tissues 13.9% in men, the cancers of skin 43.6%, oral cavity 19.8%, melanoma 18.6%, breast 17.7%, urinary tract 17.7%, genital organs 13.5% and endocrine glands 13% in women. The most multiplicities were registered in region Northern Moravia 38,547 (13.3%), Southern Moravia 34,219 (11.8%) and in Prague 34,218 (11.8%). From 125,262 patients, 18,887 (15.1%) men and 22,274 (17.8%) women survived, number of deceased persons was 46,405 (37%) men and 37,696 (30.1%) women. In the view of multiple cancers the broad education of life-style appears not to be sufficient for both the healthy population and for patients with 595 thousand cancers, expected in 2010.
Key words:
multiple cancers, primary and subsequent diseases, geographical distribution, prevalence.
Zdroje
1. ÚZIS. Zdravotnická ročenka ČR 2007. Praha: ÚZIS ČR, 2008; 260.
2. Billroth CAT. Die allgemeine chirurgische Pathologie und Therapie. Berlin: G. Reimer, 1889.
3. Boice JD, Jr, et al. Multiple primary cancers in Connecticut and Denmark. Natl Canc Inst Monogr 1985; 68.
4. Dong C, et al. Second primary neoplasms in 633,964 cancer patients in Sweden, 1958– 1996. Int J Canc 2001; 93(2): 155–161.
5. Curtis RE, et al. New malignancies among cancer survivors: SEER cancer registries 1973–2000. NCI, NIH Publ. No. 05‑5302. Bethesda: M, 2006; 492.
6. ÚZIS. Národní onkologický registr – pokyny k obsahu datové struktury. Závazné pokyny NZIS, verze 051-20060101/2. Praha: ÚZIS ČR 2005; 46.
7. Konečný M, Geryk E, Kubíček P, et al. Prevalence nádorů v ČR 1989–2005-2015.Brno: PřF MU Brno 2008; 69 s.
8. Kment M. Endoscopia moribunda vel rediviva? Čes Slov Gastroenterol a Hepatol 2009; 63(1): 3–5.
9. Geryk E, Bendová M, Kozel J. Karcinom prsu a následné primární zhoubné novotvary v ČR 1976–2005. Onkologie 2009; 3(1): 54–61.
10. Geryk E, Dítě P, Kozel J, Štampach R, Kubíček, P. Vícečetné nádory gastrointestinálního traktu v ČR v letech 1976–2005. Čes Slov Gastroenterol a Hepatol 2010; 64(1): 12–21.
11. Kubíček P, Geryk E, Štampach R, et al. Geografické rozložení vícečetných novotvarů v České republice 1976–2005. Brno: Přírodovědecká fakulta MU 2010 (v tisku).
12. Barták M, Horáková P. K dočasným reformám zdravotnictví v USA. Zdravotnictví v České republice 2009; 2(12): 60–62.
13. Ries LAG, et al.: SEER cancer statistics review, 1975–2003. Bethesda: Nat Canc Inst http://seer.cancer.gov/csr/1975-2003, based on Nov. 2005, SEER data submission, 2006.
14. Mariotto A. Personal communication. Div. of Canc. Control. and Population Sci, NCI. In: Curtis RE, et al. New malignancies among cancer survivors: SEER cancer registries 1973–2000. NCI, NIH Publ. No. 05-5302, Bethesda 2006; 1.
15. Fraumeni J, jr. Overall risk of subsequent cancers. In: Curtis RE, et al. New malignancies among cancer survivors: SEER cancer registries 1973–2000. NCI, NIH Publ. No. 05-5302, Bethesda 2006; 3.
16. CDC-LAF. A national action plan for cancer survivorship: Advancing public health strategies. Centers for Disease Control and Prevention, Lance Armstrong Foundation, Atlanta, 2004.
17. Geryk E, Ditě P, Odehnal J. Nádory jako (ne)snesitelná lehkost bytí. Zdravotnictví v České republice 2009; 4(12): 134–137.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- Plasma citrulline concentration – a reliable noninvasive marker of functional enterocyte mass
- Inflammatory bowel disease and pregnancy
- Cancer multiplicities in the Czech population
- Examination of exhaled breath condensate in cystic fibrosis